Navigation Links
Indevus Announces Presentation of Pagoclone Data at 47th Annual New,Clinical Drug Evaluation Unit Meeting

de effects such as sedation and withdrawal. The precise mechanism of action is unknown, however, GABA is believed to be an important neurotransmitter in the brain that may be disrupted in people who stutter. Pagoclone enhances the activity in GABA circuits in the brain and thus may help restore more normal function in speech areas of the brain.

About Indevus

Indevus Pharmaceuticals, Inc. is a specialty pharmaceutical company engaged in the acquisition, development and commercialization of products to treat conditions in urology and endocrinology. The Company's approved products include SANCTURA(R) for overactive bladder, VANTAS(R) for advanced prostate cancer, and DELATESTRYL(R) to treat male hypogonadism, all of which are currently marketed, as well as SUPPRELIN(R) LA, which was recently approved for central precocious puberty. The Indevus development pipeline contains multiple compounds within the Company's core therapeutic areas in addition to several partnered or partnerable programs. The most advanced compounds in development include SANCTURA XR(TM), the once-daily formulation of SANCTURA, VALSTAR(R) for bladder cancer, NEBIDO(R) for male hypogonadism, PRO 2000 for the prevention of infection by HIV and other sexually-transmitted pathogens, and pagoclone for stuttering.

Forward-Looking Statements

Except for the descriptions of historical facts contained herein, this press release contains forward-looking statements that involve risks and uncertainties that could cause the Company's actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties are set forth in the Company's filings under the Securities Act of 1933 and the Securities Exchange Act of 1934 under "Risk Factors" and elsewhere, and include, but are not limited to: dependence on the success of SANCTURA(R), SANCTURA XR(TM), NEBIDO(R) and VANTAS(R); the early state of products under developme
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Indevus Reports Positive Data From Phase III NEBIDO Trial
2. Antisoma Announces Further Data From ASA404 Ovarian Cancer Trial
3. Neose Announces Presentation of Positive Preclinical Data on GlycoPEGylated Factor VIIa at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Biofrontera AG Announces Clinical Study Confirms Excellent Efficacy of BF-200 ALA In Actinic Keratosis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
7. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
8. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. Protox Announces Positive Clinical Data from Prostate Cancer Study
11. Inspire Announces Webcast of Presentation at C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
Post Your Comments:
(Date:5/22/2015)... 2015 /CNW/ - The Taskforce representing Canada,s ... the hard work that the Minister and Health Canada have ... program recognizes the needs of the thalidomide survivors, and more ... year, tax free, with annual adjustments for inflation. ... payments of $100,000 based on the severity of their disability, ...
(Date:5/22/2015)... , 22 de mayo de 2015 ... DPRX ), una compañía farmacéutica de fase ... de Locilex® (pexiganan cream 0.8%), y colaboradores ... presentación de póster destacando el diseño innovador ... de la Compañía que evalúan Locilex®, su ...
(Date:5/22/2015)... N.C. , May 22, 2015  Effective ... to pharmaceutical brand recognition and success. ... conducted a study to provide pharmaceutical and biotech ... investment (FTEs and budget) that are being channeled ... and biotech marketing managers can utilize this report ...
Breaking Medicine Technology:Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 2Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 3Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 4Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 5Dipexium anuncia presentación en el séptimo Simposio Internacional sobre el Pie Diabético 6Effective Marketing Services Group Critical for Pharmaceutical Brand Recognition 2
... Mass., March 22, 2011 Generex Biotechnology Corporation ... GNBT ) announced today that Company management will ... March 30, 2011 to discuss its strategic development ... (Logo: https://photos.prnewswire.com/prnh/20110106/NY25057LOGO-b) Soon after his ...
... March 22, 2011 Instrumentation Laboratory (IL) today announced ... ($644.9 million US). This represents 11.5% growth v. previous ... the Company,s two major business segments, Critical Care and ... (11.9% in local currencies) and 9.7% (8.9% in local ...
Cached Medicine Technology:Generex Schedules Press Conference & Investor Call for March 30th to Discuss Management's Strategic Development Plan for Future Growth 2Generex Schedules Press Conference & Investor Call for March 30th to Discuss Management's Strategic Development Plan for Future Growth 3Instrumentation Laboratory Achieves Record Sales in 2010 2Instrumentation Laboratory Achieves Record Sales in 2010 3
(Date:5/22/2015)... May 22, 2015 Pioneer Millworks, the ... the forefront of designing with reclaimed wood, introducing their ... Los Angeles, California. Their newest offerings, Vat 35, ... surface and color to America's largest design event. , ... at each show, anxious to see and feel the ...
(Date:5/22/2015)... (PRWEB) May 22, 2015 River Valley ... Kyle Johnson, the health system’s Chief Financial Officer (CFO), ... Johnson has served as the company CFO since 2011. ... will be joining the health system as CFO. Wesley ... interim basis, while the Board of Trustees conducts a ...
(Date:5/22/2015)... Hershey, Pa. (PRWEB) May 22, 2015 ... has been selected to participate in the 2015 Congress ... event is described as a gathering of “America’s highest ... about new areas of healthcare, set new goals and ... will include a live surgery, during which we can ...
(Date:5/22/2015)... 22, 2015 “It’s like learning ... RAC-CT, CHHRP-QT, Vice President of Clinical Operations/Education and ... ‘language’ that impacts how care is coded and ... long term care reimbursement, operations and compliance consulting, ... talent management, launches a new series of day-long ...
(Date:5/22/2015)... 22, 2015 Coordinating care for ... process. Historically providers have not been reimbursed or ... in 2015, Medicare has paved the way by ... to the launch of Oculus Health , ... systems using the platform will now be able ...
Breaking Medicine News(10 mins):Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 2Health News:Pioneer Millworks to Reveal New Design Trends with Reclaimed Wood at Dwell on Design in LA 3Health News:River Valley Health Partners Announces CFO Transition, Appointment of Interim CFO 2Health News:Milton Hershey School Student Chosen for Congress of Future Medical Leaders 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3Health News:Oculus Health Care Coordination Platform Officially Launched 2Health News:Oculus Health Care Coordination Platform Officially Launched 3Health News:Oculus Health Care Coordination Platform Officially Launched 4
... (HealthDay News) -- If your New Year,s resolution involves losing ... your goal into small, manageable parts that you can work ... the number on the scale the focus, look for other ... the Methodist Weight Management Center at Methodist Hospital in Houston, ...
... , MONDAY, Dec. 27 (HealthDay News) -- ... impact on weight gain and could affect their future ... research suggests. "Events early in life have long-term ... influences is early growth rate," study lead author Julie ...
... , SATURDAY, Dec. 25 (HealthDay News) -- For allergy sufferers ... relief from respiratory symptoms, an expert suggests. Dust from ... plants and more can cause all sorts of breathing problems, ... in Melrose Park, Ill. In a news release from Loyola ...
... , SUNDAY, Dec. 26 (HealthDay News) -- How do people ... human being and not a replica such as a doll or ... are crucial to helping people distinguish real faces from those that ... and knowing that the lights are on and someone is home," ...
... HealthDay Reporter , FRIDAY, Dec. 24 (HealthDay News) -- ... 1999. "I would wake up very stiff and achy," said ... a while to get going in the morning." Then, after ... woke up one morning and it was like I was paralyzed," ...
... CAResearchers at the Salk Institute for Biological Studies have discovered ... when cells run low on energy, revs up a cellular ... times of need. In a paper published in the ... team led by Reuben Shaw, PhD., Howard Hughes Medical Institute ...
Cached Medicine News:Health News:Dieting Resolution Works Best When Done in Stages: Expert 2Health News:Type of Formula May Influence Infant Weight Gain 2Health News:Have an Allergy-Free Holiday and a Happier New Year 2Health News:For California Woman, Lupus Is Life 2Health News:How cells running on empty trigger fuel recycling 2Health News:How cells running on empty trigger fuel recycling 3
... Testing System: The D-10 Hemoglobin Testing ... package. It provides a fully automated system ... into a single platform. Programs for rapid ... screen away and can be easily integrated ...
... 70 hematology system delivers a ... Designed for speed and accuracy, ... cost-effectiveness with impressive productivity. The ... on its own or twinned ...
Ac.T 5diff CP allows quick and direct access to a closed sample tubea feature that reduces manual sample handling, saves time and enhances safety by eliminating operators exposure to biohazards....
... The LH 755 simplifies and ... integrating expert automation and advanced ... delivers reliable, accurate results every ... best slide quality with its ...
Medicine Products: